The muscle mitogen-activated protein kinase is altered in sporadic inclusion body myositis

被引:10
作者
Li, M [1 ]
Dalakas, MC [1 ]
机构
[1] NINDS, Neuromuscular Dis Sect, NIH, Bethesda, MD 20892 USA
关键词
muscle mitogen-activated protein kinase; sporadic inclusion body myositis;
D O I
10.1212/WNL.54.8.1665
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To examine the origin of hyperphosphorylated proteins within the vacuolated myofibers in sporadic inclusion body myositis (s-IBM) and search for dysregulated intracellular protein phosphorylation. Background: s-IBM is morphologically characterized by primary endomysial inflammation and vacuolated myofibers containing tubulofilaments that originate from cytoskeletal proteins. Mitogen-activated protein kinases (MAPKs) play a role in regulating phosphorylation and maintaining the stability of the cytoskeletal architecture. Methods: Muscle biopsies from seven patients with s-IBM and 15 controls were examined for the expression of the active components of the various MAPKs, including p44/42MAPK, p38MAPK, p46JNK1, p54JNK2, and p54JNK3, using immunocytochemistry and Western blot analysis. The expression of selected phosphorylated components was also examined in the same specimens. Results: In a-IBM, but not the disease controls, the vacuolated muscle fibers express active p42MAPK but not JNK or p38MAPK. Western blots of cell lysates confirmed the hyperexpression of p42MAPK and demonstrated a novel 35 kD phosphoprotein. Antibodies against phosphoepitopes of the 55 kD protein preferentially immunostained antigens within the vacuolated muscle fibers of s-IBM but not disease controls. Conclusion: In s-IBM, there is increased p42MAPK activation and abnormal intracellular protein phosphorylation with selective accumulation of a 35 kD phosphoprotein within the vacuolated fibers. Although the hyperexpression of 35kD protein may represent cytoskeletal by-products due to heightened p42MAPK activation, its abundant expression only in s-IBM implies that hyperphosphorylated myofibrillar proteins may be involved in the primary disease process.
引用
收藏
页码:1665 / 1669
页数:5
相关论文
共 29 条
[1]  
ASKANAS V, 1994, AM J PATHOL, V144, P177
[2]   Sporadic inclusion-body myositis and hereditary inclusion-body myopathies - Diseases of oxidative stress and aging? [J].
Askanas, V ;
Engel, WK .
ARCHIVES OF NEUROLOGY, 1998, 55 (07) :915-920
[3]   Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases [J].
Bennett, AM ;
Tonks, NK .
SCIENCE, 1997, 278 (5341) :1288-1291
[4]   ERKS - A FAMILY OF PROTEIN-SERINE THREONINE KINASES THAT ARE ACTIVATED AND TYROSINE PHOSPHORYLATED IN RESPONSE TO INSULIN AND NGF [J].
BOULTON, TG ;
NYE, SH ;
ROBBINS, DJ ;
IP, NY ;
RADZIEJEWSKA, E ;
MORGENBESSER, SD ;
DEPINHO, RA ;
PANAYOTATOS, N ;
COBB, MH ;
YANCOPOULOS, GD .
CELL, 1991, 65 (04) :663-675
[5]   Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc [J].
Chen, W ;
Martindale, JL ;
Holbrook, NJ ;
Liu, YS .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (09) :5178-5188
[6]   Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies [J].
Choi, YC ;
Dalakas, MC .
NEUROLOGY, 2000, 54 (01) :65-71
[7]   Inclusion body myositis in HIV-1 and HTLV-1 infected patients [J].
Cupler, EJ ;
LeonMonzon, M ;
Miller, J ;
SeminoMora, C ;
Anderson, TL ;
Dalakas, MC .
BRAIN, 1996, 119 :1887-1893
[8]   Molecular immunology and genetics of inflammatory muscle diseases [J].
Dalakas, MC .
ARCHIVES OF NEUROLOGY, 1998, 55 (12) :1509-1512
[9]   Treatment of inclusion-body myositis with IVIg: A double-blind, placebo-controlled study [J].
Dalakas, MC ;
Sonies, B ;
Dambrosia, J ;
Sekul, E ;
Cupler, E ;
Sivakumar, K .
NEUROLOGY, 1997, 48 (03) :712-716
[10]   MITOCHONDRIAL MYOPATHY CAUSED BY LONG-TERM ZIDOVUDINE THERAPY [J].
DALAKAS, MC ;
ILLA, I ;
PEZESHKPOUR, GH ;
LAUKAITIS, JP ;
COHEN, B ;
GRIFFIN, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (16) :1098-1105